Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIIB | AMGN | GILD | VRTX | ILMN |
| Company | Biogen Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 200.57 | 337.03 | 84.39 | 477.70 | 134.92 |
| High | 204.18 | 338.70 | 84.65 | 482.96 | 136.19 |
| Low | 200.11 | 334.61 | 83.57 | 476.27 | 133.88 |
| Last | 203.24 | 337.49 | 84.48 | 483.23 | 135.56 |
| Change | +5.65 | +4.57 | +0.59 | +9.07 | +4.59 |
| % Change | +2.86% | +1.37% | +0.70% | +1.91% | +3.50% |
| Volume | 530,787 | 653,828 | 3,708,987 | 384,760 | 515,592 |
| 20-Day Average Volume | 797,132 | 1,710,155 | 6,431,765 | 958,540 | 1,317,933 |
| Previous Close | 197.59 | 332.92 | 83.89 | 474.16 | 130.97 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 201.73 | 329.64 | 80.11 | 480.05 | 129.24 |
| 20-Day Raw Stochastic | 80.67% | 90.60% | 97.17% | 52.70% | 94.78% |
| 20-Day Relative Strength | 48.40% | 58.53% | 73.21% | 51.20% | 61.36% |
| Weighted Alpha | -20.28 | +27.70 | +19.64 | +34.95 | +9.49 |
| Today's Opinion | 88% Sell | 96% Buy | 88% Buy | 56% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 88% Buy | 40% Buy | 64% Buy |
| Last Month's Opinion | 88% Sell | 88% Buy | 56% Buy | 88% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.06% since 09/12/24 | +2.14% since 09/12/24 | +1.76% since 09/12/24 | +0.60% since 09/12/24 | +7.18% since 09/12/24 |
| Low | 192.25 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 | 126.31 on 09/13/24 |
| High | 204.18 on 09/19/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 | 136.13 on 09/19/24 |
| 1-Month | |||||
| %Chg | -1.02% since 08/19/24 | +2.79% since 08/19/24 | +13.66% since 08/19/24 | -1.33% since 08/19/24 | -0.43% since 08/19/24 |
| Low | 192.25 on 09/13/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 | 120.51 on 09/12/24 |
| High | 207.59 on 08/21/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 137.18 on 08/20/24 |
| 3-Month | |||||
| %Chg | -8.81% since 06/18/24 | +10.17% since 06/18/24 | +34.00% since 06/18/24 | +3.05% since 06/18/24 | +25.18% since 06/18/24 |
| Low | 192.25 on 09/13/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 103.52 on 06/28/24 |
| High | 238.00 on 07/12/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | -6.71% since 03/19/24 | +24.06% since 03/19/24 | +15.27% since 03/19/24 | +15.98% since 03/19/24 | +1.62% since 03/19/24 |
| Low | 189.44 on 04/19/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 100.08 on 05/30/24 |
| High | 238.00 on 07/12/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 144.19 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 28,768,510 | 178,589,936 | 104,514,608 | 122,358,416 | 20,863,522 |
| Shares Outstanding, K | 145,597 | 536,435 | 1,245,853 | 258,053 | 159,300 |
| Annual Sales | 9,835,600,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 4,504,000,000 |
| Annual Net Income | 1,161,100,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | -1,161,000,000 |
| Last Quarter Sales | 2,464,900,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 1,112,000,000 |
| Last Quarter Net Income | 583,600,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | -1,988,000,000 |
| 60-Month Beta | -0.06 | 0.61 | 0.18 | 0.40 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | 5.28 on 08/01/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 0.36 on 08/06/24 |
| Latest Earnings Date | 08/01/24 | 10/29/24 | 11/05/24 | 11/04/24 | 08/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 12.19 | 17.89 | 17.67 | 0.00 | 141.53 |